Global MicroRNA Market Size Worth USD 2977.79 Million By 2030 | CAGR 12.25%: Infinium Global Research

Infinium Global Research, a pioneering market research firm, has unveiled a comprehensive report dissecting the nuances of the Global MicroRNA market. This report offers an in-depth analysis of segments and sub-segments within the global and regional microRNA markets. It also elucidates the influential drivers, restraints, and macro indicators shaping both short-term and long-term market trends.

The meticulously crafted study presents a holistic view of trends, forecasts, and monetary values, providing a robust overview of the evolving global microRNA market.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1164

Market Insight:

The global microRNA market, valued at USD 1,224.89 million in 2022, is forecasted to surge to USD 2,977.79 million by 2030, exhibiting a noteworthy Compound Annual Growth Rate (CAGR) of 12.25% during the forecast period spanning from 2023 to 2030.

MicroRNAs, diminutive RNA molecules crucial for regulating gene expression, bind to messenger RNAs, thereby modulating protein production. These molecules, smaller than other forms of RNA, hold immense potential in cancer research, both in detection and treatment. Their investigation for cancer detection and management has sparked substantial interest within the field of oncology research. Notably, the stability in various biological samples and their dysregulated expression in cancer render microRNAs desirable for cancer research, particularly in ovarian cancer.

Market Drivers and Opportunities:

The market's growth is propelled by an increasing number of clinical trials for chronic diseases linked to miRNAs, fostering demand for miRNA-based diagnostics and therapies. The market surge is also driven by the shift towards personalized medicine, aiming for tailored patient care based on molecular profiles. However, safety and toxicity concerns in services pose restraints to market growth. Yet, technological advancements, particularly in next-generation sequencing (NGS), offer opportunities by enabling the discovery of novel miRNAs and characterization of miRNA functions.

Regional Insights:

The market segmentation spans North America, Europe, Asia Pacific, and the rest of the world. North America is anticipated to claim a significant share, driven by increased clinical trials, especially in the USA, and the presence of major market participants. Conversely, the Asia Pacific region foresees the fastest growth rate due to high disease prevalence, particularly in cancer, cardiovascular conditions, and infectious diseases. The region's demand for specialized diagnostics and treatments is escalating, with miRNAs proving effective as disease-specific biomarkers and therapeutic targets.

Segmentation and Key Players:

The report segments the microRNA market based on product & service, application, and end-user, encompassing profiling, localization, quantification, cancer, neurological diseases, pharma & biotech companies, academic & research institutes, healthcare facilities, among others.

Companies profiled in the report include Merck KGaA, Thermo Fisher Scientific Inc., Horizon Discovery Ltd., QIAGEN, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString Technologies, Inc., BioGenex, and SeqMatic LLC.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/1164

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. MicroRNA Market Highlights

2.2. MicroRNA Market Projection

2.3. MicroRNA Market Regional Highlights

Chapter 3. Global MicroRNA Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Product & Service

3.4.2. IGR-Growth Matrix Analysis by Application

3.4.3. IGR-Growth Matrix Analysis by End User

3.4.4. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of MicroRNA Market

Chapter 4. MicroRNA Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global MicroRNA Market

5.2. Companies Profiles

5.2.1. Merck KGaA

5.2.2. Thermo Fisher Scientific Inc.

5.2.3. Horizon Discovery Ltd.

5.2.4. QIAGEN

5.2.5. GeneCopoeia, Inc.

5.2.6. New England Biolabs

5.2.7. Quantabio

5.2.8. NanoString Technologies, Inc.

5.2.9. BioGenex

5.2.10. SeqMatic LLC.

Chapter 6. Global MicroRNA Market by Product & Service

6.1. Profiling

6.2. Localization

6.3. Quantification

Chapter 7. Global MicroRNA Market by Application

7.1. Cancer

7.2. Neurological Disease

Chapter 8. Global MicroRNA Market by End User

8.1. Pharma & Biotech Companies

8.2. Academic & Research Institutes

8.3. Healthcare Facilities

8.4. Others

Chapter 9. Global MicroRNA Market by Region 2023-2030

9.1. North America

9.1.1. North America MicroRNA Market by Product & Service

9.1.2. North America MicroRNA Market by Application

9.1.3. North America MicroRNA Market by End User

9.1.4. North America MicroRNA Market by Country

9.1.4.1. The U.S. MicroRNA Market

9.1.4.1.1. The U.S. MicroRNA Market by Product & Service

9.1.4.1.2. The U.S. MicroRNA Market by Application

9.1.4.1.3. The U.S. MicroRNA Market by End User

9.1.4.2. Canada MicroRNA Market

9.1.4.2.1. Canada MicroRNA Market by Product & Service

9.1.4.2.2. Canada MicroRNA Market by Application

9.1.4.2.3. Canada MicroRNA Market by End User

9.1.4.3. Mexico MicroRNA Market

9.1.4.3.1. Mexico MicroRNA Market by Product & Service

9.1.4.3.2. Mexico MicroRNA Market by Application

9.1.4.3.3. Mexico MicroRNA Market by End User

9.2. Europe

9.2.1. Europe MicroRNA Market by Product & Service

9.2.2. Europe MicroRNA Market by Application

9.2.3. Europe MicroRNA Market by End User

9.2.4. Europe MicroRNA Market by Country

9.2.4.1. Germany MicroRNA Market

9.2.4.1.1. Germany MicroRNA Market by Product & Service

9.2.4.1.2. Germany MicroRNA Market by Application

9.2.4.1.3. Germany MicroRNA Market by End User

9.2.4.2. United Kingdom MicroRNA Market

9.2.4.2.1. United Kingdom MicroRNA Market by Product & Service

9.2.4.2.2. United Kingdom MicroRNA Market by Application

9.2.4.2.3. United Kingdom MicroRNA Market by End User

9.2.4.3. France MicroRNA Market

9.2.4.3.1. France MicroRNA Market by Product & Service

9.2.4.3.2. France MicroRNA Market by Application

9.2.4.3.3. France MicroRNA Market by End User

9.2.4.4. Italy MicroRNA Market

9.2.4.4.1. Italy MicroRNA Market by Product & Service

9.2.4.4.2. Italy MicroRNA Market by Application

9.2.4.4.3. Italy MicroRNA Market by End User

9.2.4.5. Rest of Europe MicroRNA Market

9.2.4.5.1. Rest of Europe MicroRNA Market by Product & Service

9.2.4.5.2. Rest of Europe MicroRNA Market by Application

9.2.4.5.3. Rest of Europe MicroRNA Market by End User

9.3. Asia Pacific

9.3.1. Asia Pacific MicroRNA Market by Product & Service

9.3.2. Asia Pacific MicroRNA Market by Application

9.3.3. Asia Pacific MicroRNA Market by End User

9.3.4. Asia Pacific MicroRNA Market by Country

9.3.4.1. China MicroRNA Market

9.3.4.1.1. China MicroRNA Market by Product & Service

9.3.4.1.2. China MicroRNA Market by Application

9.3.4.1.3. China MicroRNA Market by End User

9.3.4.2. Japan MicroRNA Market

9.3.4.2.1. Japan MicroRNA Market by Product & Service

9.3.4.2.2. Japan MicroRNA Market by Application

9.3.4.2.3. Japan MicroRNA Market by End User

9.3.4.3. India MicroRNA Market

9.3.4.3.1. India MicroRNA Market by Product & Service

9.3.4.3.2. India MicroRNA Market by Application

9.3.4.3.3. India MicroRNA Market by End User

9.3.4.4. South Korea MicroRNA Market

9.3.4.4.1. South Korea MicroRNA Market by Product & Service

9.3.4.4.2. South Korea MicroRNA Market by Application

9.3.4.4.3. South Korea MicroRNA Market by End User

9.3.4.5. Australia MicroRNA Market

9.3.4.5.1. Australia MicroRNA Market by Product & Service

9.3.4.5.2. Australia MicroRNA Market by Application

9.3.4.5.3. Australia MicroRNA Market by End User

9.3.4.6. Rest of Asia-Pacific MicroRNA Market

9.3.4.6.1. Rest of Asia-Pacific MicroRNA Market by Product & Service

9.3.4.6.2. Rest of Asia-Pacific MicroRNA Market by Application

9.3.4.6.3. Rest of Asia-Pacific MicroRNA Market by End User

9.4. RoW

9.4.1. RoW MicroRNA Market by Product & Service

9.4.2. RoW MicroRNA Market by Application

9.4.3. RoW MicroRNA Market by End User

9.4.4. RoW MicroRNA Market by Sub-region

9.4.4.1. Latin America MicroRNA Market

9.4.4.1.1. Latin America MicroRNA Market by Product & Service

9.4.4.1.2. Latin America MicroRNA Market by Application

9.4.4.1.3. Latin America MicroRNA Market by End User

9.4.4.2. Middle East MicroRNA Market

9.4.4.2.1. Middle East MicroRNA Market by Product & Service

9.4.4.2.2. Middle East MicroRNA Market by Application

9.4.4.2.3. Middle East MicroRNA Market by End User

9.4.4.3. Africa MicroRNA Market

9.4.4.3.1. Africa MicroRNA Market by Product & Service

9.4.4.3.2. Africa MicroRNA Market by Application

9.4.4.3.3. Africa MicroRNA Market by End User

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/1164

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of MicroRNA.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.